{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:26:46Z","timestamp":1783636006244,"version":"3.55.0"},"reference-count":134,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T00:00:00Z","timestamp":1630195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","award":["GA UK 328121; SVV UK 260 548"],"award-info":[{"award-number":["GA UK 328121; SVV UK 260 548"]}],"id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["reg. No. CZ.02.1.01\/0.0\/0.0\/18_069\/0010046"],"award-info":[{"award-number":["reg. No. CZ.02.1.01\/0.0\/0.0\/18_069\/0010046"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is a progressive age-related neurodegenerative disease recognized as the most common form of dementia among elderly people. Due to the fact that the exact pathogenesis of AD still remains to be fully elucidated, the treatment is only symptomatic and available drugs are not able to modify AD progression. Considering the increase in life expectancy worldwide, AD rates are predicted to increase enormously, and thus the search for new AD drugs is urgently needed. Due to their complex nitrogen-containing structures, alkaloids are considered to be promising candidates for use in the treatment of AD. Since the introduction of galanthamine as an antidementia drug in 2001, Amaryllidaceae alkaloids (AAs) and further isoquinoline alkaloids (IAs) have been one of the most studied groups of alkaloids. In the last few years, several compounds of new structure types have been isolated and evaluated for their biological activity connected with AD. The present review aims to comprehensively summarize recent progress on AAs and IAs since 2010 up to June 2021 as potential drugs for the treatment of AD.<\/jats:p>","DOI":"10.3390\/molecules26175240","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T04:07:28Z","timestamp":1630382848000},"page":"5240","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer\u2019s Disease"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1555-8870","authenticated-orcid":false,"given":"Lucie","family":"Cahl\u00edkov\u00e1","sequence":"first","affiliation":[{"name":"ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Vrabec","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Pidan\u00fd","sequence":"additional","affiliation":[{"name":"ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roz\u00e1lie","family":"Pe\u0159inov\u00e1","sequence":"additional","affiliation":[{"name":"ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4227-7855","authenticated-orcid":false,"given":"Negar","family":"Maafi","sequence":"additional","affiliation":[{"name":"ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3441-8814","authenticated-orcid":false,"given":"Abdullah Al","family":"Mamun","sequence":"additional","affiliation":[{"name":"ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Ritomsk\u00e1","sequence":"additional","affiliation":[{"name":"ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8941-6771","authenticated-orcid":false,"given":"Viriyanata","family":"Wijaya","sequence":"additional","affiliation":[{"name":"ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Blunden","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, Hampshire P01 2DT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3233\/JAD-160484","article-title":"Alzheimer\u2019s and Parkinson\u2019s diseases: Expected economic impact on Europe\u2014A call for a Uniform European Strategy","volume":"54","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.arr.2014.03.008","article-title":"Alzheimer\u2019s disease, enzyme targets and drug discovery struggles: From natural products to drug prototypes","volume":"15","author":"Silva","year":"2014","journal-title":"Ageing Res. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer\u2019s disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Nichols","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11095-014-1522-0","article-title":"Drug access to the central nervous system in Alzheimer\u2019s disease: Preclinical and clinical insights","volume":"32","author":"Mehta","year":"2015","journal-title":"Pharm. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2013.07.004","article-title":"Therapeutics of Alzheimer\u2019s disease: Past, present and future","volume":"76","author":"Anand","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1515\/revneuro-2017-0049","article-title":"Recent studies on cellular and molecular mechanisms in Alzheimer\u2019s disease: Focus on epigenetic factors and histone deacetylase","volume":"29","author":"Dubey","year":"2018","journal-title":"Rev. Neurosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/14737175.2015.995637","article-title":"Advances in the therapy of Alzheimer\u2019s disease: Targeting amyloid beta and tau and perspectives for the future","volume":"15","author":"Hampel","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0955-0674(00)00172-1","article-title":"Going new places using an old MAP: Tau, microtubules and human neurodegenerative disease","volume":"13","author":"Garcia","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00232-010-9250-9","article-title":"Nonneuronal cholinergic system in human erythrocytes: Biological role and clinical relevance","volume":"234","author":"Saldanha","year":"2010","journal-title":"J. Membr. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/B978-0-444-63281-4.00006-9","article-title":"Chapter 6\u2014Natural compounds (small molecules) as potential and real drugs of Alzheimer\u2019s disease: A critical review","volume":"Volume 42","author":"Rahman","year":"2014","journal-title":"Studies in Natural Products Chemistry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2174\/156720512799015127","article-title":"Biochemical differentiation of cholinesterases from normal and Alzheimer\u2019s disease cortex","volume":"9","author":"Ciro","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cbi.2008.04.047","article-title":"Association between acetylcholinesterase and beta-amyloid peptide in Alzheimer\u2019s cerebrospinal fluid","volume":"175","author":"Silveyra","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-511X-4-18","article-title":"Serum butyrylcholinesterase in type 2 diabetes mellitus: A biochemical and bioinformatics approach","volume":"4","author":"Sridhar","year":"2005","journal-title":"Lipids Health Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1021\/acschemneuro.9b00041","article-title":"Autoimmune attack of the neuromuscular junction in myasthenia gravis: Nicotinic acetylcholine receptors and other targets","volume":"10","author":"Paz","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0065-2423(04)38006-6","article-title":"Organophosphates\/nerve agent poisoning: Mechanism of action, diagnosis, prophylaxis, and treatment","volume":"38","author":"Bajgar","year":"2004","journal-title":"Adv. Clin. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer\u2019s disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-3-7091-6467-9_24","article-title":"The role of glutamate in dementia","volume":"53","author":"Kornhuber","year":"1998","journal-title":"J. Neural. Transm. Suppl."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1016\/j.febslet.2008.10.026","article-title":"The role of glycogen synthase kinase 3 in the early stages of Alzheimer\u2019s disease","volume":"582","author":"Avila","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer\u2019s disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"25457","DOI":"10.1074\/jbc.M603469200","article-title":"The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation","volume":"281","author":"Plattner","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3233\/JAD-2008-15204","article-title":"GSK-3 inhibitors: A ray of hope for the treatment of Alzheimer\u2019s disease?","volume":"15","author":"Martinez","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3892\/mmr.2014.2040","article-title":"Monoamine oxidase inhibitors: Promising therapeutic agents for Alzheimer\u2019s disease (Review)","volume":"9","author":"Cai","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40169-017-0181-2","article-title":"A perspective on multi-target drug discovery and design for complex diseases","volume":"7","author":"Ramsay","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13195-017-0279-1","article-title":"Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with \u03b3-secretase and regulates neuronal amyloid \u03b2-peptide levels","volume":"9","author":"Inoue","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"104558","DOI":"10.1016\/j.phrs.2019.104558","article-title":"Prolyl oligopeptidase inhibition activates autophagy via protein phosphatase 2A","volume":"151","author":"Svarcbahs","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/138920308783565723","article-title":"Structure, function and biological relevance of prolyl oligopeptidase","volume":"9","author":"Szeltner","year":"2008","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1097\/00001756-200110290-00032","article-title":"Brain prolyl oligopeptidase activity is associated with neuronal damage rather than beta-amyloid accumulation","volume":"12","author":"Laitinen","year":"2001","journal-title":"Neuroreport"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2006.10.004","article-title":"On the role of prolyl oligopeptidase in health and disease","volume":"41","year":"2007","journal-title":"Neuropeptides"},{"key":"ref_32","first-page":"759","article-title":"Outcomes of Alzheimer\u2019s disease therapy with acetylcholinesterase inhibitors and memantine","volume":"13","author":"Zemek","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_33","first-page":"pyu115","article-title":"Combination therapy with cholinesterase inhibitors and memantine for Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"18","author":"Matsunaga","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e14781","DOI":"10.15252\/emmm.202114781","article-title":"Aducanumab: A new phase in therapeutic development for Alzheimer\u2019s disease?","volume":"13","author":"Lalli","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"n1503","DOI":"10.1136\/bmj.n1503","article-title":"Three FDA advisory panel members resign over approval of Alzheimer\u2019s drug","volume":"373","author":"Mahase","year":"2021","journal-title":"BMJ"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.373.6553.373","article-title":"Alzheimer\u2019s drug approval spotlights blood tests","volume":"373","author":"Servick","year":"2021","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1021\/acs.chemrev.8b00504","article-title":"Structural simplification of natural products","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/jphp.12090","article-title":"Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer\u2019s disease","volume":"65","author":"Konrath","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/1570159X11311040004","article-title":"Natural AChE inhibitors from plants and their contribution to Alzheimer\u2019s disease therapy","volume":"11","author":"Murray","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3389\/fphar.2018.01192","article-title":"Naturally occurring acetylcholinesterase inhibitors and their potential use for Alzheimer\u2019s disease therapy","volume":"9","author":"Gomes","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1039\/C9NP00010K","article-title":"Natural cholinesterase inhibitors from marine organisms","volume":"36","author":"Moodie","year":"2019","journal-title":"Nat. Prod. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.2174\/0929867326666190618113613","article-title":"Natural products as potential anti-Alzheimer agents","volume":"27","author":"Panda","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"ref_43","first-page":"51","article-title":"Chapter 4\u2014Isolation of alkaloids","volume":"Volume 23A","author":"Svendsen","year":"1983","journal-title":"Chromatography of Alkaloids"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/188065a0","article-title":"Quantitative isolation of alkaloids from plant materials","volume":"188","author":"Lee","year":"1960","journal-title":"Nature"},{"key":"ref_45","first-page":"1","article-title":"Extraction, isolation and characterization of bioactive compounds from plants\u2019 extracts","volume":"8","author":"Sasidharan","year":"2011","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1021\/ed068p700","article-title":"Alkaloids: Isolation and purification","volume":"68","author":"Maldoni","year":"1991","journal-title":"J. Chem. Educ."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1021\/cr078198u","article-title":"Chemistry, biology, and medicinal potential of narciclasine and its congeners","volume":"108","author":"Kornienko","year":"2008","journal-title":"Chem. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Cahl\u00edkov\u00e1, L., Breiterov\u00e1, K., and Opletal, L. (2020). Chemistry and biological activity of alkaloids from the genus Lycoris (Amaryllidaceae). Molecules, 25.","DOI":"10.3390\/molecules25204797"},{"key":"ref_49","first-page":"113","article-title":"Chapter Two\u2014Chemodiversity, chemotaxonomy and chemoecology of Amaryllidaceae alkaloids","volume":"Volume 83","year":"2020","journal-title":"The Alkaloids: Chemistry and Biology"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Xu, T., Chen, W., Zhou, J., Dai, J., Li, Y., and Zhao, Y. (2020). Virtual screening for reactive natural products and their probable artifacts of solvolysis and oxidation. Biomolecules, 10.","DOI":"10.3390\/biom10111486"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12272-013-0188-1","article-title":"Four new compounds from the bulbs of Lycoris aurea with neuroprotective effects against CoCl\u2082 and H\u2082O\u2082-induced SH-SY5Y cell injuries","volume":"37","author":"Jin","year":"2014","journal-title":"Arch. Pharm. Res."},{"key":"ref_52","first-page":"447","article-title":"Solvent derived artifacts in natural products chemistry","volume":"4","author":"Maltese","year":"2009","journal-title":"Nat. Prod. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/0031-9422(73)80415-7","article-title":"Tertiary dihydroprotoberberine alkaloids of Berberis lycium","volume":"12","author":"Miana","year":"1973","journal-title":"Phytochemistry"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11101-015-9451-z","article-title":"The Amaryllidaceae alkaloids: Biosynthesis and methods for enzyme discovery","volume":"15","author":"Kilgore","year":"2016","journal-title":"Phytochem. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1016\/j.bmcl.2017.09.052","article-title":"Antibacterial constituents of the plant family Amaryllidaceae","volume":"27","author":"Nair","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Al Mamun, A., Ma\u0159\u00edkov\u00e1, J., Hulcov\u00e1, D., Janou\u0161ek, J., \u0160afratov\u00e1, M., Nov\u00e1kov\u00e1, L., Ku\u010dera, T., Hrabinov\u00e1, M., Kune\u0161, J., and Kor\u00e1be\u010dn\u00fd, J. (2020). Amaryllidaceae alkaloids of belladine-type from Narcissus pseudonarcissus cv. carlton as new selective inhibitors of butyrylcholinesterase. Biomolecules, 10.","DOI":"10.3390\/biom10050800"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2165\/00002512-199609010-00006","article-title":"Galanthamine","volume":"9","author":"Fulton","year":"1996","journal-title":"Drugs Aging"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1212\/WNL.54.12.2261","article-title":"Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group","volume":"54","author":"Raskind","year":"2000","journal-title":"Neurology"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Chackalamannil, S., Rotella, D., and Ward, S.E. (2017). 5.14\u2014Therapeutic approaches to MS and other neurodegenerative diseases. Comprehensive Medicinal Chemistry III, Elsevier.","DOI":"10.1016\/B978-0-12-803200-8.05001-X"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/S0024-3205(02)02034-9","article-title":"Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts","volume":"71","author":"Bastida","year":"2002","journal-title":"Life Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12272-017-1000-4","article-title":"Alkaloids from Narcissus poeticus cv. Pink Parasol of various structural types and their biological activity","volume":"41","author":"Machado","year":"2018","journal-title":"Arch. Pharm. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"112055","DOI":"10.1016\/j.phytochem.2019.112055","article-title":"Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch Master as potential drugs in treatment of Alzheimer\u2019s disease","volume":"165","author":"Jun","year":"2019","journal-title":"Phytochemistry"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"104567","DOI":"10.1016\/j.bioorg.2020.104567","article-title":"Alkaloids of Zephyranthes citrina (Amaryllidaceae) and their implication to Alzheimer\u2019s disease: Isolation, structural elucidation and biological activity","volume":"107","author":"Jun","year":"2021","journal-title":"Bioorg. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Ma\u0159\u00edkov\u00e1, J., Mamun, A.A., Shammari, L.A., Kor\u00e1be\u010dn\u00fd, J., Ku\u010dera, T., Hulcov\u00e1, D., Kune\u0161, J., Malan\u00edk, M., Va\u0161kov\u00e1, M., and Kohelov\u00e1, E. (2021). Structure elucidation and cholinesterase inhibition activity of two new minor Amaryllidaceae alkaloids. Molecules, 26.","DOI":"10.3390\/molecules26051279"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"104650","DOI":"10.1016\/j.fitote.2020.104650","article-title":"Isolation, in vitro evaluation and molecular docking of acetylcholinesterase inhibitors from South African Amaryllidaceae","volume":"146","author":"Sibanyoni","year":"2020","journal-title":"Fitoterapia"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"80114","DOI":"10.1039\/C6RA20205E","article-title":"Isolation of Amaryllidaceae alkaloids from Nerine bowdenii W. Watson and their biological activities","volume":"6","author":"Opletal","year":"2016","journal-title":"RSC Adv."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-2004-818919","article-title":"Acetylcholinesterase enzyme inhibitory effects of Amaryllidaceae alkaloids","volume":"70","author":"Elgorashi","year":"2004","journal-title":"Planta Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jep.2011.07.028","article-title":"Isolation of narciprimine from Cyrtanthus contractus (Amaryllidaceae) and evaluation of its acetylcholinesterase inhibitory activity","volume":"137","author":"Nair","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.sajb.2020.03.017","article-title":"Molecular approach to promising cholinesterase inhibitory effect of several Amaryllidaceae alkaloids: Further re-investigation","volume":"136","author":"Orhan","year":"2021","journal-title":"S. Afr. J. Bot."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s12272-014-0397-2","article-title":"Alkaloids from the bulbs of Lycoris longituba and their neuroprotective and acetylcholinesterase inhibitory activities","volume":"38","author":"Zhu","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"ref_71","first-page":"1541","article-title":"Alkaloids from Chlidanthus fragrans and their acetylcholinesterase, butyrylcholinesterase and prolyl oligopeptidase activities","volume":"8","author":"Chlebek","year":"2013","journal-title":"Nat. Prod. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Hulcov\u00e1, D., Breiterov\u00e1, K., Siatka, T., Kl\u00edmov\u00e1, K., Davani, L., \u0160afratov\u00e1, M., Ho\u0161\u0165\u00e1lkov\u00e1, A., De Simone, A., Andrisano, V., and Cahl\u00edkov\u00e1, L. (2018). Amaryllidaceae alkaloids as potential glycogen synthase kinase-3\u03b2 inhibitors. Molecules, 23.","DOI":"10.3390\/molecules23040719"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Al Shammari, L., Hulcov\u00e1, D., Ma\u0159\u00edkov\u00e1, J., Ku\u010dera, T., \u0160afratov\u00e1, M., Nov\u00e1kov\u00e1, L., Schmidt, M., Pulkr\u00e1bkov\u00e1, L., Janou\u0161ek, J., and Soukup, O. (2020). Amaryllidaceae alkaloids from Hippeastrum X hybridum cv. Ferrari, and preparation of vittatine derivatives as potential ligands for Alzheimer\u2019s disease. S. Afr. J. Bot., 137\u2013146.","DOI":"10.1016\/j.sajb.2020.06.024"},{"key":"ref_74","first-page":"787","article-title":"Revised NMR data for 9-O-demethylgalanthine: An alkaloid from Zephyranthes robusta (Amaryllidaceae) and its biological activity","volume":"9","author":"Jun","year":"2014","journal-title":"Nat. Prod. Commun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cmdc.200600303","article-title":"The natural product berberine is a human prolyl oligopeptidase inhibitor","volume":"2","author":"Tarrago","year":"2007","journal-title":"ChemMedChem"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10822-011-9478-1","article-title":"Qualitative prediction of blood-brain barrier permeability on a large and refined dataset","volume":"25","author":"Muehlbacher","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer\u2019s disease","volume":"107","author":"Zenaro","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"9466","DOI":"10.1039\/D0NJ00282H","article-title":"Synthesis, biological evaluation and molecular modeling studies of substituted N-benzyl-2-phenylethanamines as cholinesterase inhibitors","volume":"44","author":"Parravicini","year":"2020","journal-title":"N. J. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Mamun, A.A., Pidan\u00fd, F., Hulcov\u00e1, D., Ma\u0159\u00edkov\u00e1, J., Ku\u010dera, T., Schmidt, M., Catapano, M.C., Hrabinov\u00e1, M., Jun, D., and M\u00fa\u010dkov\u00e1, L. (2021). Amaryllidaceae alkaloids of norbelladine-type as inspiration for development of highly selective butyrylcholinesterase inhibitors: Synthesis, biological activity evaluation, and docking studies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158308"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/10286020.2013.864639","article-title":"Two new alkaloids from the bulbs of Lycoris sprengeri","volume":"16","author":"Wu","year":"2014","journal-title":"J. Asian Nat. Prod. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"110665","DOI":"10.1016\/j.fct.2019.110665","article-title":"Neuroprotective activity of isoquinoline alkaloids from of Chilean Amaryllidaceae plants against oxidative stress-induced cytotoxicity on human neuroblastoma SH-SY5Y cells and mouse hippocampal slice culture","volume":"132","author":"Bustamante","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.lfs.2014.12.011","article-title":"Neuroprotective activity and acetylcholinesterase inhibition of five Amaryllidaceae species: A comparative study","volume":"122","author":"Cortes","year":"2015","journal-title":"Life Sci."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Ibrakaw, A.S., Omoruyi, S.I., Ekpo, O.E., and Hussein, A.A. (2020). Neuroprotective activities of Boophone haemanthoides (Amaryllidaceae) extract and its chemical constituents. Molecules, 25.","DOI":"10.3390\/molecules25225376"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuro.2013.08.012","article-title":"Neuroprotective effects of liquiritigenin isolated from licorice roots on glutamate-induced apoptosis in hippocampal neuronal cells","volume":"39","author":"Yang","year":"2013","journal-title":"Neurotoxicology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","article-title":"Oxidative stress in neurodegenerative diseases","volume":"53","author":"Niedzielska","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1515\/znc-2003-5-613","article-title":"Antioxidant properties of galantamine hydrobromide","volume":"58","author":"Traykova","year":"2003","journal-title":"Z. Naturforsch. C J. Biosci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.biopha.2017.06.010","article-title":"Protective effects of flavonoids against Alzheimer\u2019s disease-related neural dysfunctions","volume":"93","author":"Bakhtiari","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.lfs.2018.04.026","article-title":"Amaryllidaceae alkaloids as agents with protective effects against oxidative neural cell injury","volume":"203","author":"Cortes","year":"2018","journal-title":"Life Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/13880209.2020.1841810","article-title":"Effects of Hippeastrum reticulatum on memory, spatial learning and object recognition in a scopolamine-induced animal model of Alzheimer\u2019s disease","volume":"58","author":"Hoang","year":"2020","journal-title":"Pharm. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.biopha.2018.12.013","article-title":"Neuroprotection and improvement of the histopathological and behavioral impairments in a murine Alzheimer\u2019s model treated with Zephyranthes carinata alkaloids","volume":"110","author":"Cortes","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Phillipson, J.D., Roberts, M.F., and Zenk, M.H. (1985). Plants as a source of isoquinoline alkaloids. The Chemistry and Biology of Isoquinoline Alkaloids. Proceedings in Life Sciences, Springer.","DOI":"10.1007\/978-3-642-70128-3"},{"key":"ref_93","unstructured":"Badal, S., and Delgoda, R. (2017). Chapter 9\u2014Alkaloids. Pharmacognosy: Fundamentals, Applications and Strategies, Academic Press."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1211\/jpp.58.5.0015","article-title":"Acetylcholinesterase inhibitors from Stephania venosa tuber","volume":"58","author":"Ingkaninan","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1055\/s-0030-1249814","article-title":"Alkaloids from roots of Stephania rotunda and their cholinesterase inhibitory activity","volume":"76","author":"Hung","year":"2010","journal-title":"Planta Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0031-1280126","article-title":"Bioactive isoquinoline alkaloids from Corydalis saxicola","volume":"78","author":"Huang","year":"2012","journal-title":"Planta Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/acs.jnatprod.8b00592","article-title":"Isoquinoline alkaloids from Berberis vulgaris as potential lead compounds for the treatment of Alzheimer\u2019s disease","volume":"82","author":"Opletal","year":"2019","journal-title":"J. Nat. Prod."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20130013","article-title":"Crystal structures of human cholinesterases in complex with huprine W and tacrine: Elements of specificity for anti-Alzheimer\u2019s drugs targeting acetyl- and butyryl-cholinesterase","volume":"453","author":"Nachon","year":"2013","journal-title":"Biochem. J."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"7593608","DOI":"10.1155\/2019\/7593608","article-title":"Berberine alleviates amyloid \u03b2-induced mitochondrial dysfunction and synaptic loss","volume":"2019","author":"Zhao","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_100","first-page":"5","article-title":"Berberine, a popular dietary supplement for human and animal health: Quantitative research literature analysis\u2014A review","volume":"38","author":"Wai","year":"2020","journal-title":"Anim. Sci. Pap. Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"109670","DOI":"10.1016\/j.biopha.2019.109670","article-title":"Berberine mitigates cognitive decline in an Alzheimer\u2019s Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance","volume":"121","author":"Chen","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2174\/1570159X16666180419141613","article-title":"Combating neurodegenerative diseases with the plant alkaloid berberine: Molecular mechanisms and therapeutic potential","volume":"17","author":"Dahua","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.2147\/NDT.S114846","article-title":"Role of berberine in Alzheimer\u2019s disease","volume":"12","author":"Cai","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neulet.2017.06.048","article-title":"The neuroprotective effects of Berberine against amyloid \u03b2-protein-induced apoptosis in primary cultured hippocampal neurons via mitochondria-related caspase pathway","volume":"655","author":"Liang","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.exger.2017.02.004","article-title":"Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of \u03b2-amyloid in APP\/tau\/PS1 mouse model of Alzheimer\u2019s disease","volume":"91","author":"Huang","year":"2017","journal-title":"Exp. Gerontol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.pharep.2015.03.002","article-title":"Berberine and neurodegeneration: A review of literature","volume":"67","author":"Ahmed","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.3390\/molecules16086732","article-title":"Berberine: A potential multipotent natural product to combat Alzheimer\u2019s disease","volume":"16","author":"Ji","year":"2011","journal-title":"Molecules"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.biochi.2019.04.008","article-title":"Palmatine: A review of its pharmacology, toxicity and pharmacokinetics","volume":"162","author":"Long","year":"2019","journal-title":"Biochimie"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.phytochem.2018.11.019","article-title":"Cholinesterase inhibitory isoquinoline alkaloids from Corydalis mucronifera","volume":"159","author":"Zhang","year":"2019","journal-title":"Phytochemistry"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1021\/acs.jnatprod.7b00847","article-title":"Mucroniferanines A\u2013G, isoquinoline alkaloids from Corydalis mucronifera","volume":"81","author":"Zhang","year":"2018","journal-title":"J. Nat. Prod."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"103722","DOI":"10.1016\/j.bioorg.2020.103722","article-title":"Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and A\u03b21-42 aggregation","volume":"98","author":"Plazas","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_112","first-page":"1751","article-title":"Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Chelidonium majus (Papaveraceae)","volume":"5","author":"Opletal","year":"2010","journal-title":"Nat. Prod. Commun."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.bmcl.2018.06.023","article-title":"Selective inhibition of monoamine oxidase A by chelerythrine, an isoquinoline alkaloid","volume":"28","author":"Baek","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1016\/j.bmc.2012.09.040","article-title":"Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: The case of chelerythrine","volume":"20","author":"Brunhofer","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.fitote.2016.01.008","article-title":"Application of BACE1 immobilized enzyme reactor for the characterization of multifunctional alkaloids from Corydalis cava (Fumariaceae) as Alzheimer\u2019s disease targets","volume":"109","author":"Chlebek","year":"2016","journal-title":"Fitoterapia"},{"key":"ref_116","first-page":"607","article-title":"Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava (Fumariaceae)","volume":"6","author":"Chlebek","year":"2011","journal-title":"Nat. Prod. Commun."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Siatka, T., Adamcov\u00e1, M., Opletal, L., Cahl\u00edkov\u00e1, L., Jun, D., Hrabinov\u00e1, M., Kune\u0161, J., and Chlebek, J. (2017). Cholinesterase and prolyl oligopeptidase inhibitory activities of alkaloids from Argemone platyceras (Papaveraceae). Molecules, 22.","DOI":"10.3390\/molecules22071181"},{"key":"ref_118","first-page":"1035","article-title":"Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Eschscholzia californica (Papaveraceae)","volume":"5","author":"Opletal","year":"2010","journal-title":"Nat. Prod. Commun."},{"key":"ref_119","first-page":"577","article-title":"Alkaloids from Peumus boldus and their acetylcholinesterase, butyrylcholinesterase and prolyl oligopeptidase inhibition activity","volume":"10","author":"Opletal","year":"2015","journal-title":"Nat. Prod. Commun."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/cbdv.201500033","article-title":"Isoquinoline alkaloids from Fumaria officinalis L. and their biological activities related to Alzheimer\u2019s disease","volume":"13","author":"Chlebek","year":"2016","journal-title":"Chem. Biodivers."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fitote.2015.04.004","article-title":"Isoquinoline alkaloids as prolyl oligopeptidase inhibitors","volume":"103","author":"Chlebek","year":"2015","journal-title":"Fitoterapia"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0022-2860(02)00138-2","article-title":"Configurations and conformations of sanguinarine and chelerythrine free bases stereoisomers","volume":"613","author":"Dommisse","year":"2002","journal-title":"J. Mol. Struct."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"109300","DOI":"10.1016\/j.cbi.2020.109300","article-title":"Plant isoquinoline alkaloids as potential neurodrugs: A comparative study of the effects of benzo[c]phenanthridine and berberine-based compounds on \u03b2-amyloid aggregation","volume":"334","author":"Marasco","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0031-9422(00)89796-4","article-title":"Dauricine production in cultured roots of Menispermum dauricum","volume":"36","author":"Sugimoto","year":"1994","journal-title":"Phytochemistry"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2025914","DOI":"10.1155\/2018\/2025914","article-title":"The isoquinoline alkaloid dauricine targets multiple molecular pathways to ameliorate Alzheimer-like pathological changes in vitro","volume":"2018","author":"Liu","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"9390","DOI":"10.1074\/jbc.271.16.9390","article-title":"Metabolism of the \u201cSwedish\u201d amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the \u201cbeta-secretase\u201d site occurs in the golgi apparatus","volume":"271","author":"Thinakaran","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/14786410802433971","article-title":"Effects of tetrandrine on cAMP and cGMP levels in rabbit corpus cavernosum in vitro","volume":"24","author":"Chen","year":"2010","journal-title":"Nat. Prod. Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainres.2011.01.103","article-title":"Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-\u03baB activation in a rat model of Alzheimer\u2019s disease induced by amyloid-\u03b2(1-42)","volume":"1384","author":"He","year":"2011","journal-title":"Brain Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1021\/np9000976","article-title":"Pronuciferine N-oxide, a proaporphine N-oxide alkaloid from Berberis coletioides","volume":"72","author":"Fajardo","year":"2009","journal-title":"J. Nat. Prod."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e22601","DOI":"10.1002\/jbt.22601","article-title":"Neuroactivity of naturally occurring proaporphine alkaloid, pronuciferine","volume":"34","author":"Bayazeid","year":"2020","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Kohelov\u00e1, E., Pe\u0159inov\u00e1, R., Maafi, N., Kor\u00e1be\u010dn\u00fd, J., Hulcov\u00e1, D., Ma\u0159\u00edkov\u00e1, J., Ku\u010dera, T., Mart\u00ednez Gonz\u00e1lez, L., Hrabinov\u00e1, M., and Vor\u010d\u00e1kov\u00e1, K. (2019). Derivatives of the \u03b2-crinane Amaryllidaceae alkaloid haemanthamine as multi-target directed ligands for Alzheimer\u2019s disease. Molecules, 24.","DOI":"10.3390\/molecules24071307"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"103928","DOI":"10.1016\/j.bioorg.2020.103928","article-title":"Functionalized aromatic esters of the Amaryllidaceae alkaloid haemanthamine and their in vitro and in silico biological activity connected to Alzheimer\u2019s disease","volume":"100","author":"Maafi","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1021\/acs.jnatprod.9b00561","article-title":"Aromatic esters of the crinane Amaryllidaceae alkaloid ambelline as selective inhibitors of butyrylcholinesterase","volume":"83","year":"2020","journal-title":"J. Nat. Prod."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"112593","DOI":"10.1016\/j.ejmech.2020.112593","article-title":"Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profile","volume":"203","author":"Prchal","year":"2020","journal-title":"Eur. J. Med. Chem."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/17\/5240\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:54:56Z","timestamp":1760165696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/17\/5240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,29]]},"references-count":134,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["molecules26175240"],"URL":"https:\/\/doi.org\/10.3390\/molecules26175240","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,29]]}}}